Rebecca Cutts

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 170 citations · Full text

Malnutrition in children with food allergies in the <scp>UK</scp>

Rosan Meyer, Claire De Koker, Robert Dziubak et al. · Journal of Human Nutrition and Dietetics · 2013 · 142 citations

First- and Second-Trimester Fetal Size and Asthma Outcomes at Age 10 Years

Steve Turner, Nanda Prabhu, Peter Danielian et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 81 citations

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom et al. · The Lancet · 2025 · 29 citations · Full text

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 14 citations · Full text